Stevia rebaudiana loaded titanium oxide nanomaterials as an antidiabetic agent in rats

[1]  M. E. Díaz-García,et al.  Controlled release of nafcillin using biocompatible "dummy" molecularly imprinted sol-gel nanospheres. , 2015, Current topics in medicinal chemistry.

[2]  V. Kaul,et al.  Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana. , 2013, Journal of diabetes and its complications.

[3]  B. K. Mehta,et al.  Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats , 2011, Journal of pharmacy & bioallied sciences.

[4]  J. L. Bata-García,et al.  Treatment of Parkinson’s disease: nanostructured sol–gel silica–dopamine reservoirs for controlled drug release in the central nervous system , 2010, International journal of nanomedicine.

[5]  M. Álvarez,et al.  Study of the stabilization of zinc phthalocyanine in sol-gel TiO2 for photodynamic therapy applications. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[6]  Y. Cha,et al.  Stevia rebaudiana Bertoni extract supplementation improves lipid and carnitine profiles in C57BL/6J mice fed a high-fat diet. , 2010, Journal of the science of food and agriculture.

[7]  Sanjay K. Jain,et al.  Antidiabetic potential of medicinal plants. , 2010, Acta poloniae pharmaceutica.

[8]  Ashley Nicole Roberts,et al.  Subchronic toxicity of rebaudioside A. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  A. Davey,et al.  The Neuroprotective Effects of Isosteviol against Focal Cerebral Ischemia Injury Induced by Middle Cerebral Artery Occlusion in Rats , 2008, Planta medica.

[10]  V. Suchý,et al.  [Medicinal plants and diabetes mellitus]. , 2008, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.

[11]  Sang Bok Lee,et al.  Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. , 2007, Drug discovery today.

[12]  V. Mohan,et al.  Epidemiology of type 2 diabetes: Indian scenario. , 2007, The Indian journal of medical research.

[13]  Tso‐Hsiao Chen,et al.  Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia rebaudiana. , 2005, Planta medica.

[14]  C. Barbé,et al.  Silica Particles: A Novel Drug‐Delivery System , 2004 .

[15]  A. Rašković,et al.  Glucose concentration in the blood of intact and alloxan-treated mice after pretreatment with commercial preparations of Stevia rebaudiana (Bertoni) , 2004, European Journal of Drug Metabolism and Pharmacokinetics.

[16]  A. Starratt,et al.  Rebaudioside F, a diterpene glycoside from Stevia rebaudiana. , 2002, Phytochemistry.

[17]  K. Hermansen,et al.  Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. , 2000, Metabolism: clinical and experimental.

[18]  B. Tomlinson,et al.  The effect of stevioside on blood pressure and plasma catecholamines in spontaneously hypertensive rats. , 1998, Life sciences.

[19]  N. Farnsworth,et al.  Potential sweetening agents of plant origin. III. Organoleptic evaluation of Stevia leaf herbarium samples for sweetness. , 1982, Journal of natural products.

[20]  S. Teoh,et al.  Wound healing in diabetes mellitus: traditional treatment modalities. , 2010, La Clinica terapeutica.

[21]  T Szkudelski,et al.  The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. , 2001, Physiological research.